Effect of propylene glycol on the skin penetration of drugs

被引:76
|
作者
Carrer, Victor [1 ]
Alonso, Cristina [1 ]
Pont, Merce [2 ]
Zanuy, Miriam [2 ]
Cordoba, Monica [2 ]
Espinosa, Sonia [2 ]
Barba, Clara [1 ]
Oliver, Marc A. [1 ]
Marti, Meritxell [1 ]
Coderch, Luisa [1 ]
机构
[1] CSIC, Inst Adv Chem Catalonia, IQAC, Jordi Girona 18-26, ES-08034 Barcelona, Spain
[2] Almirall R&D Ctr, Ctra Laurea Miro 408-410, Barcelona 08980, Spain
关键词
Propylene glycol; Percutaneous absorption; PAMPA; Franz cells; mu FTIR; STRATUM-CORNEUM LIPIDS; IN-VITRO; PERCUTANEOUS-ABSORPTION; INFRARED MICROSPECTROSCOPY; PERMEATION; ENHANCERS; DELIVERY; PERMEABILITY; VIVO; HYDROCORTISONE;
D O I
10.1007/s00403-019-02017-5
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Propylene glycol (PG) has been used in formulations as a co-solvent and/or to enhance drug permeation through the skin from topical preparations. Two skin in vitro permeation approaches are used to determine the effect of PG on drug penetration. The in vitro Skin-PAMPA was performed using 24 actives applied in aqueous buffer or PG. PG modulates permeability by increasing or diminishing it in the compounds with poor or high permeability, respectively. Percutaneous absorption using pigskin on Franz diffusion cells was performed on seven actives and their commercial formulations. The commercial formulations evaluated tend to have a lower permeability than their corresponding PG solutions but maintain the compound distribution in the different strata: stratum corneum, epidermis and dermis. The results indicate the enhancer properties of PG for all compounds, especially for the hydrophilic ones. Additionally, the Synchrotron-Based Fourier Transform Infrared microspectroscopy technique is applied to study the penetration of PG and the molecular changes that the vehicle may promote in the different skin layers. Results showed an increase of the areas under the curve indicating the higher amount of lipids in the deeper layers and altering the lipidic order of the bilayer structure to a more disordered lipid structure.
引用
收藏
页码:337 / 352
页数:16
相关论文
共 50 条
  • [21] PENETRATION AND BIOCONVERSION OF DRUGS IN THE SKIN
    TOJO, K
    LEE, ARC
    JOURNAL OF CHEMICAL ENGINEERING OF JAPAN, 1991, 24 (03) : 297 - 300
  • [22] SKIN IRRITANCY FROM PROPYLENE-GLYCOL
    WAHLBERG, JE
    NILSSON, G
    ACTA DERMATO-VENEREOLOGICA, 1984, 64 (04) : 286 - 290
  • [23] PENETRATION OF DRUGS THROUGH SKIN
    STOUGHTON, RB
    DERMATOLOGICA, 1976, 152 : 27 - 36
  • [24] EFFECT OF PH AND SOLUBILITY ON INVITRO SKIN PENETRATION OF METHOTREXATE FROM A 50-PERCENT V/V PROPYLENE-GLYCOL WATER VEHICLE
    VAIDYANATHAN, R
    CHAUBAL, MG
    VASAVADA, RC
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1985, 25 (01) : 85 - 93
  • [25] Efficient penetration of propylene glycol as a vehicle for intracanal medicaments.
    Cruz, EV
    Kota, K
    Iwaku, M
    Hoshino, E
    JOURNAL OF DENTAL RESEARCH, 2001, 80 (04) : 1379 - 1379
  • [26] PENETRATION OF MINOXIDIL FROM ETHANOL PROPYLENE-GLYCOL SOLUTIONS - EFFECT OF APPLICATION VOLUME AND OCCLUSION
    TATA, S
    FLYNN, GL
    WEINER, ND
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (06) : 688 - 691
  • [27] TRANSPORT OF GLYCEROL AND PROPYLENE GLYCOL ACROSS FROG SKIN
    STORELLI, C
    PESENTE, L
    LIPPE, C
    BOLLETTINO DELLA SOCIETA ITALIANA DI BIOLOGIA SPERIMENTALE, 1971, 47 (01): : 1 - &
  • [28] Measurement of Diffusion Coefficient of Propylene Glycol in Skin Tissue
    Genin, Vadim D.
    Bashkatov, Alexey N.
    Genina, Elina A.
    Tuchin, Valery V.
    SARATOV FALL MEETING 2014: OPTICAL TECHNOLOGIES IN BIOPHYSICS AND MEDICINE XVI; LASER PHYSICS AND PHOTONICS XVI; AND COMPUTATIONAL BIOPHYSICS, 2015, 9448
  • [29] HISTOLOGICAL ASPECTS OF SKIN REACTIONS TO PROPYLENE-GLYCOL
    NATER, JP
    BAAR, AJM
    HOEDEMAEKER, PJ
    CONTACT DERMATITIS, 1977, 3 (04) : 181 - 185
  • [30] Oxide terpenes as human skin penetration enhancers of haloperidol from ethanol and propylene glycol and their modes of action on stratum corneum
    Vaddi, HK
    Ho, PCL
    Chan, YW
    Chan, SY
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2003, 26 (02) : 220 - 228